Reframing small cell lung cancer: therapeutic lessons from hematologic malignancies - Top-Institutions - MDSpire

Reframing small cell lung cancer: therapeutic lessons from hematologic malignancies

By
Kanak Parmar
Ira Surolia
Anish Thomas
April 30, 2026
0 min

Frontiers In Oncology

Share

Top Institutions in Oncology

Brief introduction explaining scope and methodology.

#1

Memorial Sloan Kettering Cancer Center

New York, NY
Key Differentiators
- Thoracic Oncology
- Hematologic Malignancies
- Immunotherapy
- Translational Cancer Research
#2

Dana-Farber Cancer Institute

Boston, MA
Key Differentiators
- Thoracic Oncology
- Hematology/Oncology
- Epigenetics
- Immuno-oncology
#3

MD Anderson Cancer Center

Houston, TX
Key Differentiators
- Thoracic Oncology
- Hematologic Malignancies
- Cancer Immunotherapy
- Molecular Oncology
#4

Johns Hopkins Sidney Kimmel Comprehensive Cancer Center

Baltimore, MD
Key Differentiators
- Thoracic Oncology
- Hematology
- Cancer Biology
- Immunotherapy
#5

University of California, San Francisco (UCSF) Helen Diller Family Comprehensive Cancer Center

San Francisco, CA
Key Differentiators
- Thoracic Oncology
- Hematology/Oncology
- Epigenetics
- Immunotherapy

Original Source(s)

Frontiers In Oncology

Reframing small cell lung cancer: therapeutic lessons from hematologic malignancies

by Kanak Parmar, Ira Surolia, Anish Thomas
April 30, 2026

Related Content

Frontiers In Oncology

Case Report: Synovial sarcoma with diffuse myxoid stroma and complete absence of epithelial differentiation in the extremity

Frontiers In Oncology

Gastric-type endocervical adenocarcinoma with Peutz-Jeghers syndrome: a case report and literature review

by Jinting Li, Roufei Lu, Huisi Lin, Dan Sun, Jiangtao Fan
May 29, 2026

Frontiers In Oncology

MRI perfusion in evaluating ovarian masses: diagnostic performance of wash out rate